Article citationsMore>>
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet, 395, 497-506.
https://doi.org/10.1016/S0140-6736(20)30183-5
has been cited by the following article:
-
TITLE:
SARS-COV-2 Induce Pulmonary Injury from Basic to Clinical Research
AUTHORS:
Jinguo Zhu
KEYWORDS:
COVID-19, SARS-CoV-2, Pulmonary Injury, Clinical Manifestation, Treatment Strategies
JOURNAL NAME:
World Journal of Cardiovascular Diseases,
Vol.12 No.3,
March
31,
2022
ABSTRACT: The SARS-CoV-2 has infected over 194,909,000 cases and over 4,170,000 deaths in the world before the end of July 2021. The virus attacks human alveoli and induces severe lung injury (COVID-19 disease) and spreads rapidly. The mechanisms of COVID-19 disease are unclear. To better understand this disease, This review analyzes the SARS-CoV-2 biological characteristics, insights the effect of alveolar epithelium and its adjacent microvascular endothelium, investigates human host cells immune response and immunothrombosis. Explains clinical manifestations of COVID-19 associated lung injury. It may be helpful for development management strategies for COVID-19 associated pulmonary damage.
Related Articles:
-
Po Cui, Siyu Zhang, Yuemin Nan, Rongqi Wang
-
Kan Wu, Laner Wu, Zhenkun Huang, Yong Jiang, Yun Ma
-
Yixiao Li, Zhaoxin Dai
-
Rick W. Rorie, Pedro A. Delgado, Toby D. Lester
-
Jacques Touma